CCTA Imaging Analyst - Research (NYC Hybrid)

About Cleerly

We’re Cleerly – a healthcare company rooted in Denver, Colorado and New York, New York, that is transforming the way heart disease is diagnosed, treated, and tracked. Founded in 2017 by one of the world's leading cardiologists, our expanding team consists of top-notch engineers, operations, medical affairs, marketing, and sales leaders. Our Series C funding of $223M, raised in 2022, will facilitate rapid growth and sustain our mission.

Cleerly is setting a new standard of care for heart disease through value-based, AI-led precision diagnostic solutions, aiming to help prevent heart attacks. Our technology surpasses traditional methods of heart disease assessment by facilitating comprehensive quantification and characterization of atherosclerosis, or plaque buildup, in each of the heart's arteries. Cleerly's solutions are backed by more than ten years of conducting some of the world's most extensive clinical trials to pinpoint essential findings beyond symptoms that amplify a person's risk of heart attacks.